J. E. Baldwin et al.
Rf =0.26 (DCM/EtOAc, 19:1); m.p. 62–638C; lit. [58] 61–638C; 1H NMR
(400 MHz, CDCl3): d=2.54 (s, 1H; OH), 3.80 (s, 3H; OCH3), 4.48 (s,
2H; H1), 6.82 (d, J=9.0 Hz, 2H; H3’, 5’), 7.37 ppm (d, J=9.0 Hz, 2H;
H2’, 6’); 13C NMR (100.6 MHz, CDCl3): d=51.5 (C1), 55.3 (OCH3), 85.5
(C3), 86.0 (C2), 113.9 (C3’, 5’), 114.7 (C4’), 133.2 (C2’, 6’), 159.7 ppm
(C1’); IR (KBr): n˜max =3258 (br m, OH str), 2965 (w), 2898 (w), 2838 (w),
2231 (w, CC alkyne str), 1604 (s), 1509 (s), 1441 (m), 1292 (m), 1250 (s),
1174 (m), 1110 (w), 1028 (s), 949 (w), 837 cmÀ1 (s); MS (CI+): m/z (%):
163.2 ([MH]+, 100), 144.8 (46), 133.1 (32), 122.2 (19), 112.1 (13), 95.6
(14); HRMS ([MH]+) requires m/z 163.0759, found: 163.0767.
(m), 2934 (m), 2836 (m), 1607 (s), 1511 (s), 1463 (m), 1287 (m), 1248 (s),
1175 (s), 1033 (s), 835 (s), 756 cmÀ1 (m); MS (ES+): m/z ([MH+ÀH2O])
252.8 (100%); HRMS ([MH+ÀH2O) requires m/z 253.1229, found
253.1234.
3,4-Bis(3,4-dibenzyloxy-2-nitrophenyl)furan
(1):
4,5-Dibenzyloxy-2-nitroiodobenzene
(4; 406 mg, 0.880 mmol) and 3,4-bis(tri-n-
butylstannyl)furan (5; 271 mg, 0.420 mmol)
were coupled by using the general proce-
dure with conditions A [Pd(PPh3)4] (49 mg,
0.042 mmol), CuI (16 mg, 0.084 mmol), CsF
(255 mg, 1.68 mmol), DMF (2 mL)] for 2 h.
Column chromatography (DCM/PE, 7:3)
(Z)-3-(4’-Methoxyphenyl)-3-(tri-n-butylstannyl)-2-
propyn-1-ol (13):[59] Bu3SnH (3.65 mL, 13.6 mmol)
was added slowly to a solution of 3-(4’-methoxy-
gave 1 (284 mg, 92%) as a solid yellow foam.
phenyl)-2-propyn-1-ol (20; 2.00 g, 12.3 mmol) and
Rf =0.44 (DCM/PE, 7:3); m.p. 55.5–568C; 1H NMR (400 MHz, CDCl3):
d=5.15, (s, 4H; CH2 of Bn), 5.17 (s, 4H; CH2 of Bn), 6.87 (s, 2H; H6’,
6’’), 7.30–7.53 ppm (m, 24H; H2, H5, H3’, H3’’, Ar-H of Bn); 13C NMR
(100.6 MHz, CDCl3): d=71.1 and 71.4 (CH2 of Bn), 110.4 (C3’, 3’’), 117.0
(C6’, 6’’), 120.8 and 123.7 (quat. C), 127.2, 127.3, 127.4, 127.5, 128.17,
128.24, 128.3, 128.6 and 128.7 (Ar-CH of Bn), 135.7 and 135.9 (ipso-C of
Bn), 140.0 (C2, 5), 141.6, 147.9 and 152.3 ppm (quat. C); IR (KBr): n˜max
=3089 (w), 3063 (w), 1573 (m), 1519 (s, NO2 str), 1454 (m), 1342 (s, NO2
str), 1280 (s), 1203 (m), 1086 (m), 1023 (m), 868 (m), 738 (m), 696 cmÀ1
(m); MS (ES+): m/z (%): 752.3 ([MNH4]+, 100), 702.2 (33); HRMS
([MNH4]+) requires m/z 752.2608, found 752.2612.
[Pd(PPh3)2Cl2] (0.17 g, 0.24 mmol) in THF
(20 mL) under argon at room temperature. The dark brown mixture was
stirred for 20 min then the solvent was removed under reduced pressure.
The residue was purified by column chromatography (DCM/EtOAc,
19:1) to give 13 (2.18 g, 39%) as a pale yellow liquid.
1
Rf =0.41 (DCM/EtOAc, 19:1); H NMR (400 MHz, CDCl3): d=0.82–0.97
(m, 15H; CH2CH3 and SnCH2), 1.28 (sextet, J1 =7.0 Hz, 6H; CH2CH3),
1.37–1.53 (m, 6H; CH2CH2CH3), 1.61 (br s, 1H; OH), 3.79 (s, 3H;
OCH3), 4.13 (t, J=5.5 Hz, 2H; H1), 5.96 (t, J=6.0 Hz, 1H; H2), 6.80–
6.88 ppm (m, 4H; Ar CH); 13C NMR (100.6 MHz, CDCl3): d=10.0
(SnCH2), 13.6 (CH2CH3), 27.3 (CH2CH3), 28.9 (CH2CH2CH3), 55.2
(OCH3), 60.5 (C1), 113.5 and 136.2 (Ar CH), 136.2 (quat. C), 139.9 (C2),
148.2 and 157.5 ppm (quat. C); IR (thin film): n˜max = 3322 (br m, OH
str), 2955 (s), 2926 (s), 2871 (s), 2853 (s), 1602 (m), 1505 (s), 1464 (m),
1283 (m), 1244 (s), 1173 (m), 1036 (s), 864 cmÀ1 (m); MS (CI+): m/z
(%): 453.3 ([MH]+, (15)) 437.3 (35), 395.3 (92), 381.2 (75), 291.2 (72),
203.2 (37), 163.2 (54), 146.9 (100), 134.8 (33).
4-(Tri-n-butylstannyl)nitrobenzene (7):[35] A mixture
of 4-iodonitrobenzene (6; 5.00 g, 20.1 mmol), Bu6Sn2
(15.0 mL, 29.7 mmol) and [Pd(PPh3)4] (1.16 g,
1.00 mmol) in toluene (50 mL) was heated to reflux
under argon for 48 h. Saturated aqueous KF solution
(50 mL) was added to the cooled mixture and then it was stirred rapidly
at room temperature for 1 h. The mixture was filtered through Celite
with toluene washings (200 mL), then the organic layer was separated,
dried over Na2SO4/MgSO4 and the solvent removed under reduced pres-
sure. The residue was purified by column chromatography (PE/DCM,
9:1) to give 7 (5.21 g, 63%) as a yellow oil.
Rf =0.27 (PE/DCM, 9:1); 1H NMR (400 MHz, CDCl3): d=0.90 (t, J=
7.5 Hz, 9H; CH3), 1.04–1.22 (m, 6H; SnCH2), 1.34 (sextet, J=7.0 Hz,
6H; CH2CH3), 1.45–1.62 (m, 6H; CH2CH2CH3), 7.59–7.71 (m, 2H; H3,
5), 8.13 ppm (d, J=8.5 Hz, 2H; H2, 6); 13C NMR (100.6 MHz, CDCl3);
d=9.8 (SnCH2), 13.6 (CH3), 27.3 (CH2CH3), 29.0 (CH2CH2CH3), 121.9
(C2, 6), 137.0 (C3, 5), 148.1 and 153.3 ppm (quat. C); IR (thin film):
n˜max = 3031 (w), 2957 (s), 2928 (s), 2871 (s), 2853 (s), 1518 (s, NO2 str),
1347 (s, NO2 str), 850 cmÀ1 (m); MS (CI+): m/z (%): ([MNH4]+) 431.2
(15), 373.2 (18), 356.2 (36), 326.2 (27), 308.2 (29), 291.2 (57), 150.2 (23),
94.2 (100).
3-(2’-Carboxylic acid methyl ester)-3-(4’’-methox-
yphenyl)-2-propen-1-ol (14):[57] Methyl 2-iodoben-
zoate (12; 220 mg) and (Z)-3-(4’-methoxyphenyl)-
3-(tri-n-butylstannyl)-2-propyn-1-ol (13; 422 mg)
were coupled by using the general procedure
with conditions A for 8 h. Column chromatogra-
phy (DCM/EtOAc, 9:1) gave 14 (231 mg, 92%)
as a white solid.
Rf =0.20 (DCM/EtOAc, 9:1); m.p. 89–908C; 1H NMR (400 MHz,
CDCl3): d= 3.59 (s, 3H; OCH3), 3.79 (s, 3H; OCH3), 4.35 (d, J=7.0 Hz,
2H; H1), 5.85 (t, J=7.0 Hz, 1H; H2), 6.82 (d, J=8.0 Hz, 2H; H3’’, 5’’),
7.04 (d, J=7.5 Hz, 2H; H2’’, 6’’), 7.32–7.38 (m, 2H; H4’, 6’), 7.43–7.49
(m, 1H; H5’), 7.69 ppm (d, J=7.5 Hz, 1H; H3’); 13C NMR (100.6 MHz,
CDCl3): d= 51.9 and 55.2 (OCH3), 60.3 (C1), 113.1 (C3’, 5’), 127.4 (Ar
CH), 128.5 (C2), 129.5 (C3’’), 131.0, 131.2 and 131.3 (Ar CH), 131.4,
143.4, 143.8 and 158.9 (quat. C), 168.7 ppm (C=O), (one Ar CH and one
quat. C not seen); IR (KBr): n˜max =3427 (br m, OH str), 3007 (m), 2951
(m), 2838 (m), 1721 (s, C=O str), 1608 (s), 1511 (s), 1294 (s), 1250 (s),
1180 (m), 1127 (m), 1084 (m), 1031 (s), 838 (m), 761 cmÀ1 (s); MS
(ES+): m/z : ([MH+ÀH2O]) 280.8 (100%); HRMS ([MH]+) requires
m/z 281.1178, found 281.1172.
4’-Methyl-4-nitrobiphenyl (9): 4-Iodotoluene
8
(183 mg) and 4-(tri-n-butylstannyl)nitrobenzene 7
(383 mg) were coupled by using the general pro-
cedure with 10% [Pd(PPh3)4], 20% CuI and
2 equiv CsF for 2 h at 408C. Column chromatog-
raphy (PE/DCM, 1:1) gave 9 (176 mg, 98%) as a
cream solid.
3,3-Bis(4’-Methoxyphenyl)-2-propen-1-ol (16):[57]
4-Iodoanisole (15; 197 mg) and (Z)-3-(4’-methox-
yphenyl)-3-(tri-n-butylstannyl)-2-propyn-1-ol (13;
422 mg) were coupled by using the general proce-
dure with conditions A for 8 h. Column chroma-
tography (DCM/EtOAc, 19:1) gave 16 (213 mg,
94%) as a pale yellow liquid.
Rf =0.41 (PE/DCM, 1:1); m.p. 135–1378C; lit. [36] 138–1398C; 1H NMR
(400 MHz, CDCl3): d=2.44 (s, 3H; Ar CH3), 7.32 (d, J=8.0 Hz, 2H;
H3’, 5’), 7.53 (d, J=8.0 Hz, 2H; H2’, 6’), 7.71 (d, J=9.0 Hz, 2H; H2, 6),
8.28 ppm (d, J=9.0 Hz, 2H; H3, 5); 13C NMR (100.6 MHz, CDCl3): d=
21.2 (Ar CH3), 124.1 (C3, 5), 127.2 and 127.4 (C2, 2’, 6, 6’), 129.9 (C3’,
5’), 135.8, 139.1 146.8 and 147.5 ppm (quat. C); IR (KBr): n˜max =1594
(m), 1513 (s, NO2 str), 1484 (m), 1338 (s, NO2 str), 1107 (m), 824 (s),
754 cmÀ1 (m); MS (CI+): m/z (%): 231.2 ([MNH4]+, 20), 213.1 ([MH]+,
100), 183.1 (49), 165.1 (30), 152.1 (41); HRMS ([MH]+) requires m/z
213.0790, found 213.0790.
Rf =0.24 (DCM/EtOAc, 19:1); 1H NMR
(400 MHz, CDCl3): d=1.82 (s, 1H; OH), 3.80 (s,
3H; OCH3), 3.84 (s, 3H; OCH3), 4.21 (d, J=7.0 Hz, 2H; H1), 6.11 (t, J=
7.0 Hz, 2H; H2), 6.82 (d, J=9.0 Hz, 2H; H3’ and 5’ or 3’’ and 5’’), 6.90
(d, J=9.0 Hz, 2H; H3’ and 5’ or 3’’ and 5’’), 7.09 (d, J=9.0 Hz, 2H; H2’
and 6’ or 2’’ and 6’’), 7.20 ppm (d, J=9.0 Hz, 2H; H2’ and 6’ or 2’’ and
6’’); 13C NMR (100.6 MHz, CDCl3): d=55.2 (2ꢄOCH3), 60.7 (C1), 113.5
(C3’, 5’), 125.5 (C2), 128.9 and 131.0 (C2’, 6’), 131.6, 134.8, 143.4, 159.0
and 159.2 ppm (quat. C); IR (thin film): n˜max =3394 (br m, OH str), 3004
3-Thiophen-2-yl-pyridine (19):[60] 3-Iodopyridine (17;
172 mg) and 2-(tri-n-butylstannyl)thiophene (18; 347 mg)
were coupled by using the general procedure with condi-
tions
A for 1 h. Column chromatography (PE/diethyl
ether, 3:7) gave 19 (134 mg, 99%) as a pale yellow liquid.
3304
ꢀ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2005, 11, 3294 – 3308